Shifei Wu

611 total citations
23 papers, 491 citations indexed

About

Shifei Wu is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Shifei Wu has authored 23 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Pharmacology and 6 papers in Pharmacology. Recurrent topics in Shifei Wu's work include Plant-based Medicinal Research (4 papers), Traditional Chinese Medicine Analysis (3 papers) and Natural product bioactivities and synthesis (3 papers). Shifei Wu is often cited by papers focused on Plant-based Medicinal Research (4 papers), Traditional Chinese Medicine Analysis (3 papers) and Natural product bioactivities and synthesis (3 papers). Shifei Wu collaborates with scholars based in China and Pakistan. Shifei Wu's co-authors include Changliang Yao, Wenlong Wei, Jiayuan Li, Tao Guo, Jie Su, De‐an Guo, Le Li, Haiyang Wu, Hui Qian and De‐an Guo and has published in prestigious journals such as Molecules, Phytochemistry and RSC Advances.

In The Last Decade

Shifei Wu

23 papers receiving 488 citations

Peers

Shifei Wu
Shifei Wu
Citations per year, relative to Shifei Wu Shifei Wu (= 1×) peers Lifeng Jiang

Countries citing papers authored by Shifei Wu

Since Specialization
Citations

This map shows the geographic impact of Shifei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shifei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shifei Wu more than expected).

Fields of papers citing papers by Shifei Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shifei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shifei Wu. The network helps show where Shifei Wu may publish in the future.

Co-authorship network of co-authors of Shifei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Shifei Wu. A scholar is included among the top collaborators of Shifei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shifei Wu. Shifei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Shifei, et al.. (2024). Pharmacodynamical research of extracts and compounds in traditional Chinese medicines for Parkinson's disease. Fitoterapia. 177. 106086–106086. 4 indexed citations
2.
Li, Jiayuan, Shifei Wu, Yaling An, et al.. (2024). Diastereomers of Steroidal Alkaloids with Cytotoxic Activities against Non-Small-Cell Lung Cancer from the Bulbs of Fritillaria sinica. Journal of Natural Products. 87(2). 252–265. 2 indexed citations
3.
Wei, Wenlong, Zhenwei Li, Shiwei Li, et al.. (2023). Fingerprint profiling and gut microbiota regulation of polysaccharides from Fritillaria species. International Journal of Biological Macromolecules. 237. 123844–123844. 20 indexed citations
4.
Li, Jiayuan, Shifei Wu, Yaling An, et al.. (2023). Undescribed steroidal alkaloids from the bulbs of Fritillaria sinica. Phytochemistry. 213. 113768–113768. 5 indexed citations
5.
He, Xin, Mengyuan Wang, Shifei Wu, et al.. (2023). Microbial transformation of osthole by human intestinal fungi and anti-osteoporosis activities of its metabolites. Fitoterapia. 167. 105510–105510. 3 indexed citations
6.
Wei, Wenlong, et al.. (2022). Advances in the chemical constituents, pharmacological properties and clinical applications of TCM formula Yupingfeng San. Fitoterapia. 164. 105385–105385. 10 indexed citations
7.
Wang, Cuicui, Qirui Bi, Dongdong Huang, et al.. (2022). Identification of Pinelliae Rhizoma and its counterfeit species based on enzymatic signature peptides from toxic proteins. Phytomedicine. 107. 154451–154451. 7 indexed citations
8.
Zulfiqar, Muhammad, et al.. (2022). Behavioural Psychology of Unique Family Firms Toward R&D Investment in the Digital Era: The Role of Ownership Discrepancy. Frontiers in Psychology. 13. 928447–928447. 4 indexed citations
9.
Li, Zhenwei, Wenlong Wei, Shifei Wu, et al.. (2021). A systematic strategy integrating solid-phase extraction, full scan range splitting, mass defect filter and precursor ion list for comprehensive metabolite profiling of Danqi Tongmai tablet in rats. Journal of Pharmaceutical and Biomedical Analysis. 198. 113989–113989. 6 indexed citations
10.
Wei, Wenlong, Shifei Wu, Zhenwei Li, et al.. (2021). Chemical profiling of Huashi Baidu prescription, an effective anti-COVID-19 TCM formula, by UPLC-Q-TOF/MS. Chinese Journal of Natural Medicines. 19(6). 473–480. 23 indexed citations
12.
Ji, Hongjian, Jiayuan Li, Shifei Wu, et al.. (2020). Two New Aristolochic Acid Analogues from the Roots of Aristolochia contorta with Significant Cytotoxic Activity. Molecules. 26(1). 44–44. 10 indexed citations
13.
Tao, Zhengang, Yanqi Han, Mingming Xue, et al.. (2017). Therapeutic Mechanistic Studies of ShuFengJieDu Capsule in an Acute Lung Injury Animal Model Using Quantitative Proteomics Technology. Journal of Proteome Research. 16(11). 4009–4019. 41 indexed citations
14.
Su, Jie, Shifei Wu, Haiyang Wu, Le Li, & Tao Guo. (2015). CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β‐catenin‐FoxM1‐Twist signaling. Molecular Carcinogenesis. 55(12). 1962–1973. 72 indexed citations
15.
Wu, Shifei, Jie Su, Hui Qian, & Tao Guo. (2015). SLC27A4 regulate ATG4B activity and control reactions to chemotherapeutics-induced autophagy in human lung cancer cells. Tumor Biology. 37(5). 6943–6952. 29 indexed citations
16.
Gong, Yi, Shifei Wu, Qingping Ma, et al.. (2015). Significantly inhibitory effects of low molecular weight heparin (Fraxiparine) on the motility of lung cancer cells and its related mechanism. Tumor Biology. 36(6). 4689–4697. 19 indexed citations
17.
Su, Jie, Shifei Wu, Wei Tang, et al.. (2015). Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1‐ABCG2 signaling. Molecular Carcinogenesis. 55(11). 1822–1832. 34 indexed citations
18.
Ren, Jiang, Shifei Wu, Feng Peng, et al.. (2014). Cationic Liposome Mediated Delivery of FUS1 and hIL-12 Coexpression Plasmid Demonstrates Enhanced Activity against Human Lung Cancer. Current Cancer Drug Targets. 14(2). 167–180. 11 indexed citations
19.
Ma, Qingping, Qianqian Jiang, Qiang Pu, et al.. (2013). MicroRNA-143 Inhibits Migration and Invasion of Human Non-Small-Cell Lung Cancer and Its Relative Mechanism. International Journal of Biological Sciences. 9(7). 680–692. 58 indexed citations
20.
Li, Shuo, Yu Wang, Shan Wang, et al.. (2012). Biodegradable cyclen-based linear and cross-linked polymers as non-viral gene vectors. Bioorganic & Medicinal Chemistry. 20(4). 1380–1387. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026